Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-08-27 00:00:00 ET · period of report 2025-08-27 · accession 0001140361-25-033017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-27 | 2025-08-27 | RCKT | Bjork Elisabeth | Dir | P - Purchase | $3.41 | +10.0K | 40.0K | +33% | +$34.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-27 | P | A | 10,000 | $3.41 | 40,000 | D | — | — | (F1) Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026. |